Record #43022
Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
Original paper date
Sep 1, 2018
Original DOI
Notes from Retraction Watch
See also: https://pubpeer.com/publications/08813FDA2773E95E4D7D24E00F30DE
Citation lifecycle
How this paper is being cited
Pre-retraction
8
Same day
0
Post-retraction
4
% post-retraction
33.3%
~3.1 citations/yr before retraction · ~0.7 citations/yr after
— citing papers
Who is still citing this work
Loading…